Annual report pursuant to Section 13 and 15(d)

Earnings Per Share - Shares Used in the Earnings Per Share Computations (Details)

v3.23.2
Earnings Per Share - Shares Used in the Earnings Per Share Computations (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Earnings Per Share      
Net earnings, including noncontrolling interest $ 285,442 $ 263,099 $ 139,585
Less net earnings (loss) attributable to noncontrolling interest 179 (8,952) (825)
Net earnings attributable to Bio-Techne 285,263 272,051 140,410
Income allocated to participating securities (70) (121) (86)
Income available to common shareholders $ 285,193 $ 271,930 $ 140,324
Weighted-average shares outstanding - basic (in shares) 157,179 156,874 154,986
Earnings per share - basic (in shares) $ 1.81 $ 1.73 $ 0.91
Income available to common shareholders $ 285,193 $ 271,930 $ 140,324
Dilutive effect of stock options and restricted stock units (in shares) 4,676 7,240 6,946
Weighted-average common shares outstanding - diluted (in shares) 161,855 164,114 161,932
Earnings per share - diluted (in shares) $ 1.76 $ 1.66 $ 0.87